|
16.1.2010 |
EN |
Official Journal of the European Union |
L 11/12 |
COMMISSION DECISION
of 28 July 2009
amending the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products
(notified under document C(2009) 5804)
(Text with EEA relevance)
(2010/28/EC)
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (1), and in particular Article 16(f) thereof,
Having regard to the opinions of the European Medicines Agency, formulated on 10 January 2008 and 6 March 2008 by the Committee for Herbal Medicinal Products,
Whereas:
|
(1) |
Calendula officinalis L and Pimpinella anisum L comply with the requirements set out in Directive 2001/83/EC. Calendula officinalis L and Pimpinella anisum L can be considered as herbal substances, herbal preparations or combinations thereof. |
|
(2) |
It is therefore appropriate to include Calendula officinalis L and Pimpinella anisum L in the list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products established in Annex I to Commission Decision 2008/911/EC (2). |
|
(3) |
Decision 2008/911/EC should therefore be amended accordingly. |
|
(4) |
The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Medicinal Products for Human Use, |
HAS ADOPTED THIS DECISION:
Article 1
Decision 2008/911/EC is amended as follows:
|
1. |
Annex I is amended in accordance with Annex I to this Decision. |
|
2. |
Annex II is amended in accordance with Annex II to this Decision. |
Article 2
This Decision is addressed to the Member States.
Done at Brussels, 28 July 2009.
For the Commission
Günter VERHEUGEN
Vice-President
ANNEX I
In Annex I to Decision 2008/911/EC, the following is inserted:
|
— |
‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit), |
|
— |
‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit). |
ANNEX II
In Annex II to Decision 2008/911/EC, the following is inserted:
|
— |
‘Calendula officinalis L’ is inserted before Foeniculum vulgare Miller subsp. vulgare var. vulgare (Bitter fennel, fruit) ‘COMMUNITY LIST ENTRY ON CALENDULA OFFICINALIS L Scientific name of the plant Calendula officinalis L. Botanical family Asteraceae Herbal substance Calendula flower Common name in all EU official languages of herbal substance
Herbal preparation(s)
European Pharmacopoeia monograph reference Calendula flower – Calendulae flos (01/2005:1297) Indication(s)
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology”. Specified posology Herbal preparations:
In compresses diluted at least 1:3 with freshly boiled water. In semi-solid dosage forms: amount equivalent to 2-10 % herbal substance. As a gargle or mouth rinse in a 2 % solution. 2 to 4 times daily Indication (a) The use is not recommended in children under 6 years of age (see below “Special warnings and precautions for use”). Indication (b) The use in children under 12 years of age is not recommended because there is no experience available (see below “Special warnings and precautions for use”). Route of administration Cutaneous and oromucosal use. Duration of use or any restrictions on the duration of use Compresses: remove after 30-60 minutes All herbal preparations: If the symptoms persist after 1 week during the use of the medicinal product a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to members of the Asteraceae (Compositae) family. Special warnings and precautions for use Indication (a) The use in children under 6 years of age is not recommended because there is no experience available. Indication (b) The use in children under 12 years of age is not recommended because there is no experience available. If signs of skin infection are observed, a doctor or a qualified health care practitioner should be consulted. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation Safety during pregnancy and lactation has not been established. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines Not relevant. Undesirable effects Skin sensitisation. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose None reported.’ |
|
— |
‘Pimpinella anisum L’ is inserted after Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung (Sweet fennel, fruit) ‘COMMUNITY LIST ENTRY ON PIMPINELLA ANISUM L Scientific name of the plant Pimpinella anisum L. Botanical family Apiaceae Herbal substance Aniseed Common name in all EU official languages of herbal substance
Herbal preparation(s) Dried aniseed, comminuted or crushed European Pharmacopoeia monograph reference Anisi fructus (01/2005:0262) Indication(s)
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use. Type of tradition European Specified strength Please see “Specified posology” Specified posology Adolescents over 12 years of age, adults, elderly: Indications (a) and (b) 1 to 3,5 g of whole or (freshly (*1)) comminuted or crushed aniseed in 150 ml of boiling water as a herbal tea 3 times daily The use in children under 12 years is not recommended of age (see below “Special warnings and precautions for use”). Route of administration Oral use Duration of use or any restrictions on the duration of use Not to be taken for more than 2 weeks. If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted. Any other information necessary for the safe use Contraindications Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) (caraway, celery, coriander, dill and fennel) or to anethole. Special warnings and precautions for use The use is not recommended in children under 12 years of age due to the lack of adequate data for safety assessment. Interactions with other medicinal products and other forms of interaction None reported. Pregnancy and lactation There are no data from the use of aniseed in pregnant patients. It is unknown if aniseed constituents are excreted in human breast milk. In the absence of sufficient data, the use during pregnancy and lactation is not recommended. Effects on ability to drive and use machines No studies on the effect on the ability to drive and use machines have been performed. Undesirable effects Allergic reactions to aniseed affecting the skin or the respiratory system may occur. The frequency is not known. If other adverse reactions not mentioned above occur, a doctor or a qualified health care practitioner should be consulted. Overdose No case of overdose has been reported. |
(*1) For commercial preparations of comminuted or crushed aniseed the applicant must carry out appropriate stability testing related to the content of essential oil components.’